
Angela Duffy has been appointed as Managing Director for our European based ad hoc research teams. Angela has been an integral part of Research Partnership for 19 years, witnessing its evolution into a global organization and forming part of Inizio Advisory. Her outstanding contributions to the company’s growth and expansion has led to her well-earned appointment to this new position. Angela will now spearhead the strategic growth of our European teams, ensuring our clients receive high quality insights and solutions to their business challenges.
In addition, Grzegorz Stanczyk has joined Research Partnership as Operations Director, having previously worked at Hall and Partners. With a wealth of experience in operational strategy within the market research industry, Grzegorz will play a pivotal role in supporting our ad-hoc research teams and overseeing our Compliance and Commercial Affairs functions. His expertise in client and supplier contracting, as well as MSA negotiations, will help to enhance our operations.
Helen Cox has joined the business as Senior Commercial Director. Helen is an accomplished insights professional with over 25 years’ experience, having led client engagement across healthcare clients in her most recent role at Ipsos, both in defining the overall strategy and leading client accounts. Helen brings a wealth of experience in strengthening client partnerships, understanding clients’ businesses, and bringing the very best expertise to every engagement, which will help to strengthen our commercial strategy at Research Partnership.
CEO of Research Partnership, Gareth Phillips, commented “I am delighted to congratulate Angela on her new appointment and welcome Grzegorz and Helen to the team. Angela’s expertise will be instrumental in delivering enhanced value to our clients within the European sector. Grzegorz and Helen both bring a wealth of knowledge and fresh perspectives to our dynamic workforce, and I look forward to collaborating with them both as we strengthen our Operational and Commercial capabilities across our global teams.”
Find out more and explore a range of resources at Research Partnership.
This content was provided by Inizio
Latest Content from Inizio
All eyes on Spinraza
In this paper, experts Marc Yates, Pei Li Teh and Brett Gardiner discuss the China healthcare reforms which affect pharma and propose how to build the market understanding required to launch…
Download our pre-launch checklist
The key to conducting effective rare disease research
Download our third Innovation in #MRX webcast, hosted in partnership with Convosphere, where we discuss how to use social media listening to answer key business questions.Watch here: https://bit.ly/2nM0xvj
Given the colossal amount of personal and professional information that we share online, social media channels such as Facebook and Twitter are fast becoming treasure troves of big data. As…
Our latest infographic outlines the changes to the clinical trial process, accelerated drug approval, fast track of rare disease products and access opportunities in China’s evolving healthcare environment.Find out more here-…
Research Partnership were delighted to exhibit, sponsor and present three papers at the EphMRA conference where Director Richard Head was presented with one of this year’s MR Excellence Awards.Find out…
Research Partnership’s client was developing a novel therapy for the treatment of a rare disease in which patients suffer acute symptomatic attacks; the main burden of disease is not just…
Living with Ankylosing Spondylitis (AS) & nr-AxSpA are reports based on quantitative studies conducted online in the 5EU and US. The AS 5EU report comprises of interviews with 385 patients…
